GI Journal Club – February 24th, 2022
Article 1: Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis Clinical Gastroenterology and Hepatology 2022;20:136–144 DOI: https://doi.org/10.1016/j.cgh.2020.09.043 PDF: Article Summary: Irritable bowel syndrome (IBS) is one of the most expensive gastroenterological conditions and is an ideal target for developing a value-based care model. We assessed the comparative cost benefit of treatments […]
